Tel Aviv, L3CIK 14962014 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
94 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Inds Ltd | 1.12M | $35.07M | 7.3% | −383.5K | Reduced |
| 2 | Biogen Inc | 94.7K | $16.67M | 3.5% | +12.0K | Added |
| 3 | Mineralys Therapeutics Inc | 449.0K | $16.29M | 3.4% | +229.1K | Added |
| 4 | Syndax Pharmaceuticals Inc |
| 762.6K |
| $16.02M |
| 3.3% |
| +374.8K |
| Added |
| 5 | Nova Ltd | 47.8K | $15.71M | 3.3% | +4.0K | Added |
| 6 | Tower Semiconductor Ltd | 122.5K | $14.39M | 3.0% | −189.3K | Reduced |
| 7 | Cogent Biosciences Inc | 378.5K | $13.44M | 2.8% | +280.0K | Added |
| 8 | Astrazeneca PLC | 135.1K | $12.42M | 2.6% | 0 | Held |
| 9 | Sanofi | 239.5K | $11.61M | 2.4% | +20.0K | Added |
| 10 | Eli Lilly & Co | 9.0K | $9.72M | 2.0% | −1.0K | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio